SUBSCRIBE
SUBSCRIBE
News   FDA

Astellas Pharma Inc. Wins Japan Approval for New Transplant Drug

July 17, 2008 | 
1 min read
TOKYO, July 17 (Reuters) - Astellas Pharma Inc said on Thursday it had won approval to sell a new version of its key transplant drug in Japan, the second major region where it has gained approval although it is facing delays in the United States.
FDA Approvals Asia
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Handmade signboard with Closed inscription and striped rope hanging on pin on bright red background
Company closure
Bespoke Startup EveryONE Folds 1 Week After Plausible Mechanism Guidance
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Reaching an agreement. Businessmen shake hands and make a deal. vector
Immunology and inflammation
Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Dream Birds Flying Away, the birds flying out of a bird an open cage, the birds released from a cage, freedom concept. birds set free vector illustration.
Gene therapy
Intellia’s CRISPR Gene Therapy Free To Move Forward After FDA Fully Lifts Hold
March 3, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration showing hurdles along a path ending in an arrow
Complete response letters
REGENXBIO’s Hunter Rejection Hinged on Inadequate Controls, Surrogate Endpoint
March 3, 2026
 · 
2 min read
 · 
Tristan Manalac